
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Gut Microbiota: A Potential Gateway to Improved Health Outcomes in Breast Cancer Treatment and Survivorship
Kara Sampsell, Desirée Hao, Raylene A. Reimer
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 9239-9239
Open Access | Times Cited: 48
Kara Sampsell, Desirée Hao, Raylene A. Reimer
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 9239-9239
Open Access | Times Cited: 48
Showing 1-25 of 48 citing articles:
Estrogens and the risk of breast cancer: A narrative review of literature
Khayry Al‐Shami, Sajeda Awadi, Almu’atasim Khamees, et al.
Heliyon (2023) Vol. 9, Iss. 9, pp. e20224-e20224
Open Access | Times Cited: 45
Khayry Al‐Shami, Sajeda Awadi, Almu’atasim Khamees, et al.
Heliyon (2023) Vol. 9, Iss. 9, pp. e20224-e20224
Open Access | Times Cited: 45
Obesity and breast cancer
Dara Bakar, Raman Mehrzad
Elsevier eBooks (2022), pp. 83-113
Closed Access | Times Cited: 65
Dara Bakar, Raman Mehrzad
Elsevier eBooks (2022), pp. 83-113
Closed Access | Times Cited: 65
Role of Gut Microbiota Dysbiosis in Breast Cancer and Novel Approaches in Prevention, Diagnosis, and Treatment
Sheila W Ruo, Tasnim Alkayyali, Myat Thu Thu Win, et al.
Cureus (2021)
Open Access | Times Cited: 62
Sheila W Ruo, Tasnim Alkayyali, Myat Thu Thu Win, et al.
Cureus (2021)
Open Access | Times Cited: 62
Characteristics of the Gut Bacterial Composition in People of Different Nationalities and Religions
Mikhail Syromyatnikov, Ekaterina Nesterova, Maria Gladkikh, et al.
Microorganisms (2022) Vol. 10, Iss. 9, pp. 1866-1866
Open Access | Times Cited: 45
Mikhail Syromyatnikov, Ekaterina Nesterova, Maria Gladkikh, et al.
Microorganisms (2022) Vol. 10, Iss. 9, pp. 1866-1866
Open Access | Times Cited: 45
The gut microbiota in breast cancer development and treatment: The good, the bad, and the useful!
Deeptashree Nandi, Sheetal Parida, Dipali Sharma
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 36
Deeptashree Nandi, Sheetal Parida, Dipali Sharma
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 36
Physical Exercise and the Hallmarks of Breast Cancer: A Narrative Review
Celia García-Chico, Susana López‐Ortiz, Saúl Peñín‐Grandes, et al.
Cancers (2023) Vol. 15, Iss. 1, pp. 324-324
Open Access | Times Cited: 29
Celia García-Chico, Susana López‐Ortiz, Saúl Peñín‐Grandes, et al.
Cancers (2023) Vol. 15, Iss. 1, pp. 324-324
Open Access | Times Cited: 29
The Emerging Role of the Microbiota in Breast Cancer Progression
Giancarla Bernardo, Valentino Le Noci, Martina Di Modica, et al.
Cells (2023) Vol. 12, Iss. 15, pp. 1945-1945
Open Access | Times Cited: 23
Giancarla Bernardo, Valentino Le Noci, Martina Di Modica, et al.
Cells (2023) Vol. 12, Iss. 15, pp. 1945-1945
Open Access | Times Cited: 23
Nano-Based Theranostic Platforms for Breast Cancer: A Review of Latest Advancements
Rabia Arshad, Maria Hassan Kiani, Abbas Rahdar, et al.
Bioengineering (2022) Vol. 9, Iss. 7, pp. 320-320
Open Access | Times Cited: 33
Rabia Arshad, Maria Hassan Kiani, Abbas Rahdar, et al.
Bioengineering (2022) Vol. 9, Iss. 7, pp. 320-320
Open Access | Times Cited: 33
Modulating Microbiota as a New Strategy for Breast Cancer Prevention and Treatment
Huixin Wu, Sebanti Ganguly, Trygve O. Tollefsbol
Microorganisms (2022) Vol. 10, Iss. 9, pp. 1727-1727
Open Access | Times Cited: 33
Huixin Wu, Sebanti Ganguly, Trygve O. Tollefsbol
Microorganisms (2022) Vol. 10, Iss. 9, pp. 1727-1727
Open Access | Times Cited: 33
Stachydrine represses the proliferation and enhances cell cycle arrest and apoptosis of breast cancer cells via PLA2G2A/DCN axis
Zhen Zhai, Tianlong Mu, Lina Zhao, et al.
Chemical Biology & Drug Design (2024) Vol. 103, Iss. 1
Closed Access | Times Cited: 5
Zhen Zhai, Tianlong Mu, Lina Zhao, et al.
Chemical Biology & Drug Design (2024) Vol. 103, Iss. 1
Closed Access | Times Cited: 5
The Role of Gut Microbiota in Modulating Cancer Therapy Efficacy
Mostafa A. Madkour, Rawan A. Altaf, Zeinab S. Sayed, et al.
Advanced Gut & Microbiome Research (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 5
Mostafa A. Madkour, Rawan A. Altaf, Zeinab S. Sayed, et al.
Advanced Gut & Microbiome Research (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 5
Bacterial metabolites: Effects on the development of breast cancer and therapeutic efficacy (Review)
Yan Guo, Wenyan Dong, Dezheng Sun, et al.
Oncology Letters (2025) Vol. 29, Iss. 4, pp. 1-9
Open Access
Yan Guo, Wenyan Dong, Dezheng Sun, et al.
Oncology Letters (2025) Vol. 29, Iss. 4, pp. 1-9
Open Access
Epigenetic Landscapes of Aging in Breast Cancer Survivors: Unraveling the Impact of Therapeutic Interventions—A Scoping Review
Nikita Nikita, Zhengyang Sun, Swapnil Sharma, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 866-866
Open Access
Nikita Nikita, Zhengyang Sun, Swapnil Sharma, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 866-866
Open Access
Combination of gut microbiota, proinflammatory cytokine, and 18F-FDG PET as potential indicators for predicting breast cancer recurrence
Jeongshin An, Bom Sahn Kim, Hai‐Jeon Yoon
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Jeongshin An, Bom Sahn Kim, Hai‐Jeon Yoon
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Microbiome Assisted Tumor Microenvironment: Emerging Target of Breast Cancer
Rama Rao Malla, Rakshmitha Marni, Seema Kumari, et al.
Clinical Breast Cancer (2021) Vol. 22, Iss. 3, pp. 200-211
Closed Access | Times Cited: 38
Rama Rao Malla, Rakshmitha Marni, Seema Kumari, et al.
Clinical Breast Cancer (2021) Vol. 22, Iss. 3, pp. 200-211
Closed Access | Times Cited: 38
A straightforward access to trifluoromethylated natural products through late-stage functionalization
Heping Li, Xiang‐Hong He, Cheng Peng, et al.
Natural Product Reports (2022) Vol. 40, Iss. 5, pp. 988-1021
Closed Access | Times Cited: 26
Heping Li, Xiang‐Hong He, Cheng Peng, et al.
Natural Product Reports (2022) Vol. 40, Iss. 5, pp. 988-1021
Closed Access | Times Cited: 26
The Chemo-Gut Pilot Study: Associations between Gut Microbiota, Gastrointestinal Symptoms, and Psychosocial Health Outcomes in a Cross-Sectional Sample of Young Adult Cancer Survivors
Julie Deleemans, Faye Chleilat, Raylene A. Reimer, et al.
Current Oncology (2022) Vol. 29, Iss. 5, pp. 2973-2994
Open Access | Times Cited: 22
Julie Deleemans, Faye Chleilat, Raylene A. Reimer, et al.
Current Oncology (2022) Vol. 29, Iss. 5, pp. 2973-2994
Open Access | Times Cited: 22
Interactions between the tumor microbiota and breast cancer
Hua Guo
Frontiers in Cellular and Infection Microbiology (2025) Vol. 14
Open Access
Hua Guo
Frontiers in Cellular and Infection Microbiology (2025) Vol. 14
Open Access
Microbiome-mediated immune modulation in tumor microenvironment
John O. Richards, Eleanor L. Davis, L. Shakila, et al.
International review of cell and molecular biology (2025)
Closed Access
John O. Richards, Eleanor L. Davis, L. Shakila, et al.
International review of cell and molecular biology (2025)
Closed Access
Advances in understanding therapeutic mechanisms of probiotics in cancer management, with special emphasis on breast cancer: a comprehensive review
As Angel Nama, G Mary Sandeepa, Buddolla Viswanath, et al.
European Journal of Pharmacology (2025), pp. 177410-177410
Closed Access
As Angel Nama, G Mary Sandeepa, Buddolla Viswanath, et al.
European Journal of Pharmacology (2025), pp. 177410-177410
Closed Access
Metabolic dysfunction-associated steatotic liver disease: A sexually dimorphic disease and breast and gynecological cancer
Xinrong Zhang, Mindie H. Nguyen
Metabolism (2025), pp. 156190-156190
Closed Access
Xinrong Zhang, Mindie H. Nguyen
Metabolism (2025), pp. 156190-156190
Closed Access
Control of Redox Homeostasis by Short-Chain Fatty Acids: Implications for the Prevention and Treatment of Breast Cancer
Carmen González‐Bosch, Patricia A. Zunszain, Giovanni E. Mann
Pathogens (2023) Vol. 12, Iss. 3, pp. 486-486
Open Access | Times Cited: 12
Carmen González‐Bosch, Patricia A. Zunszain, Giovanni E. Mann
Pathogens (2023) Vol. 12, Iss. 3, pp. 486-486
Open Access | Times Cited: 12
Effect of Chemotherapy on the Gut Microbiome of Breast Cancer Patients During the First Year of Treatment
Anna H. Wu, Cheryl Vigen, Chiu-Chen Tseng, et al.
Breast Cancer Targets and Therapy (2022) Vol. Volume 14, pp. 433-451
Open Access | Times Cited: 17
Anna H. Wu, Cheryl Vigen, Chiu-Chen Tseng, et al.
Breast Cancer Targets and Therapy (2022) Vol. Volume 14, pp. 433-451
Open Access | Times Cited: 17
Unraveling the connections between gut microbiota, stress, and quality of life for holistic care in newly diagnosed breast cancer patients
Chi‐Chan Lee, Horng‐Woei Yang, Chih-Ju Liu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Chi‐Chan Lee, Horng‐Woei Yang, Chih-Ju Liu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Gut Microbiota: A Potential Target for Cancer Interventions
Hu Zhou, Yuan Yuan, Haorun Wang, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 8281-8296
Open Access | Times Cited: 21
Hu Zhou, Yuan Yuan, Haorun Wang, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 8281-8296
Open Access | Times Cited: 21